Novo Nordisk says Wegovy pill shows comparable weight-loss to injectable version

(Reuters) -Novo Nordisk’s experimental Wegovy pill showed a 16.6% weight-loss in a late-stage study, according to data published in The New England Journal of Medicine on Wednesday, which is comparable to previous trial results of injectable Wegovy.

(Reporting by Puyaan Singh in Bengaluru; Editing by Shinjini Ganguli)